These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 5763886)
1. A pH pattern for I.V. additives. Webb JW Am J Hosp Pharm; 1969 Jan; 26(1):31-5. PubMed ID: 5763886 [No Abstract] [Full Text] [Related]
2. pH--an important factor in the compatibility of additives in intravenous therapy. Mary Edward Sister Am J Hosp Pharm; 1967 Aug; 24(8):440-9. PubMed ID: 6075729 [No Abstract] [Full Text] [Related]
3. Compatibility of various admixtures with secondary additives at Y-injection sites of intravenous administration sets. Allen LV; Levinson RS; Phisutsinthop D Am J Hosp Pharm; 1977 Sep; 34(9):939-43. PubMed ID: 20779 [No Abstract] [Full Text] [Related]
4. The availability of antibiotics in combination with other additives in intravenous solutions. Dancey JW; Carew DP Am J Hosp Pharm; 1966 Oct; 23(10):543-51. PubMed ID: 5915776 [No Abstract] [Full Text] [Related]
5. Problems of intravenous additives. Ryan F RANF Rev; 1977 Jan; 8(1):1, 3. PubMed ID: 585112 [No Abstract] [Full Text] [Related]
6. Visual compatibility of ondansetron hydrochloride with selected drugs during simulated Y-site injection. Trissel LA; Tramonte SM; Grilley BJ Am J Hosp Pharm; 1991 May; 48(5):988-92. PubMed ID: 1830190 [No Abstract] [Full Text] [Related]
7. Unipen injection. Parker EA Am J Hosp Pharm; 1971 Dec; 28(12):975-6. PubMed ID: 5135193 [No Abstract] [Full Text] [Related]
9. Visual compatibility of enalaprilat with selected intravenous medications during simulated Y-site injection. Thompson DF; Allen LV; Stiles ML Am J Hosp Pharm; 1990 Nov; 47(11):2530-1. PubMed ID: 2177585 [No Abstract] [Full Text] [Related]
10. Continuous versus intermittent intravenous antibiotics. Med Lett Drugs Ther; 1968 Jul; 10(15):57-8. PubMed ID: 5667663 [No Abstract] [Full Text] [Related]
11. Visual compatibility of amsacrine with selected drugs during simulated Y-site injection. Trissel LA; Chandler SW; Folstad JT Am J Hosp Pharm; 1990 Nov; 47(11):2525-8. PubMed ID: 2278268 [No Abstract] [Full Text] [Related]
12. Drug incompatibility from the standpoint of the intravenous route of drug administration. Williams JT Hosp Manage; 1968 Jan; 105(1):38 passim. PubMed ID: 5634868 [No Abstract] [Full Text] [Related]
13. Intravenous admixture incompatibility information program. Donn R Bull Parenter Drug Assoc; 1970; 24(2):98-103. PubMed ID: 5439919 [No Abstract] [Full Text] [Related]
14. Incompatibility of drugs for intravenous administration. Med Lett Drugs Ther; 1967 Aug; 9(17):67-8. PubMed ID: 6050661 [No Abstract] [Full Text] [Related]
15. [Chemical changes due to the compounding of parenteral injections. (1)]. Kosugi T Iryo; 1967 Aug; 21(8):960-1. PubMed ID: 5582998 [No Abstract] [Full Text] [Related]
17. [Physical and chemical incompatibilities of drug associations in syringes and perfusion bottles]. Léopold G Anesth Analg (Paris); 1971; 28(5):879-86. PubMed ID: 5158891 [No Abstract] [Full Text] [Related]
18. Intravenous drug incompatibilities. Morris ME Am J Nurs; 1979 Jul; 79(7):1288-91. PubMed ID: 36757 [No Abstract] [Full Text] [Related]
19. Intravenous therapy. 4. The meaning of incompatibility; specific group incompatibilities. Williams JT; Moravec DF Hosp Manage; 1966 Apr; 101(4):87-8. PubMed ID: 5907995 [No Abstract] [Full Text] [Related]